In past years, the failure rate of Alzheimer’s drugs has been alarmingly high. In fact, as recently as 2020, 99 percent of investigational drug products failed and never made it to market. Not only is Alzheimer’s an expensive disease, but its symptoms are also devastating for patients and families. The United States is on the clock to produce drugs and treatments to help the symptoms, slow progression and ultimately find a cure, and Congress’s funding for biomedical research is an investment worth making. Without a cure, the cost of Alzheimer’s and other related dementias will certainly bankrupt our nation. Based on estimates from the Alzheimer’s Association this year, Alzheimer's and
Hence then, the article about biomedical research improves access to alzheimer s treatments was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Biomedical research improves access to Alzheimer’s treatments )